Skip to main content

Lisata Therapeutics, Inc.

LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000320017

No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −2 vs. previous quarter
31
13F valueReported value at the end of Q2 2026
$3.70M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding LSTA, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding LSTA at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Lisata Therapeutics, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 10, 2021 (view filing)Dec 82 daysMyers Steven SDirectorPPurchase+33.8K$0.89+$30.1K+29.9%146.8K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Lisata Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 31 holders
Institutions holding LSTA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Capital Management LLC278,837$948.0K0.00%+7,022+2.6%Added
Yakira Capital Management, Inc.138,561$471.1K0.14%+138,561New
CSS LLC110,422$375.4K0.02%+48,524+78.4%Added
Deltec Asset Management LLC83,197$282.9K0.04%−6,803−7.6%Reduced
Rangeley Capital, LLC81,000$275.4K0.26%+6,000+8.0%Added
Geode Capital Management, LLC72,632$247.0K0.00%+1,745+2.5%Added
Virtu Financial LLC58,782$200.0K0.01%+16,569+39.3%Added
BlackRock, Inc.54,857$186.5K0.00%00.0%Unchanged
Vanguard Fiduciary Trust Co48,964$166.5K0.00%+14,047+40.2%Added
GTS Securities LLC30,200$102.7K0.00%−1,196−3.8%Reduced